These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4201539)

  • 1. [Inhibitory action of Corynebacterium parvum on the development of malignant syngenic tumors, and its mechanism].
    Halpern B; Fray A; Crepin Y; Platica O; Sparros L; Lorinet AM; Rabourdin A
    C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(12):1911-5. PubMed ID: 4201539
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of macrophage activation by Corynebacterium parvum. I. In vitro experiments.
    Christie GH; Bomford R
    Cell Immunol; 1975 May; 17(1):141-9. PubMed ID: 1092470
    [No Abstract]   [Full Text] [Related]  

  • 4. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
    [No Abstract]   [Full Text] [Related]  

  • 5. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
    Yuhas JM; Ullrich RL
    Cancer Res; 1976 Jan; 36(1):161-6. PubMed ID: 1247995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-tumour cytostatic and cytotoxic properties of peritoneal exudate cells of conventional and germ-free mice, stimulated or not by "Corynebacterium parvum" (author's transl)].
    Fray A; Moreau C; Thobie N; Ducluzeau R
    Ann Immunol (Paris); 1982; 133C(1):33-43. PubMed ID: 7092174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antiviral properties of Corynebacterium parvum].
    Cerutti I
    C R Acad Hebd Seances Acad Sci D; 1974 Sep; 279(11):963-6. PubMed ID: 4376977
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.
    Smith SE; Scott MT
    Br J Cancer; 1972 Oct; 26(5):361-7. PubMed ID: 4343677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
    Fisher B; Wolmark N; Coyle J
    J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism of the antitumor immunity potentiated by anaerobic Corynebacterium parvum].
    Miyata H
    Fukuoka Igaku Zasshi; 1983 Jul; 74(7):451-69. PubMed ID: 6662469
    [No Abstract]   [Full Text] [Related]  

  • 12. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Corynebacterium acnes on interferon production in mouse peritoneal exudate cells.
    Fischbach J; Glasgow LA
    Infect Immun; 1975 Jan; 11(1):80-5. PubMed ID: 234914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)].
    Fray A; Lorinet AM; Thobie N; Halpern B
    Ann Immunol (Paris); 1979; 130C(3):445-59. PubMed ID: 475346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro anti-tumour properties of peritoneal exudate cells of conventional germ-free and stimulated mice.
    Fray A; Lorinet AM; Halpern B
    Dev Biol Stand; 1977 Apr 13-15; 38():241-4. PubMed ID: 608509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Corynebacterium parvum after intraperitoneal injection in hamsters.
    Duthu A; Alexandrov I; Le Goffic N; De Vaux St Cyr C
    Dev Comp Immunol; 1984; 8(1):231-6. PubMed ID: 6233193
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of Corynebacterium parvum on the activity of glycosidases and proteases of peritoneal macrophages in the mice].
    Scharfman A; Houdret N; Roussel P; Biserte G
    C R Acad Hebd Seances Acad Sci D; 1978 Sep; 287(4):317-20. PubMed ID: 102445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
    Ghaffar A; Cullen RT; Woodruff MA
    Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
    Kiya K; Toge T; Harada K; Uozumi T; Hattori T
    Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumour effects of Corynebacterium parvum in mice.
    Castro JE
    Eur J Cancer (1965); 1974 Feb; 10(2):121-7. PubMed ID: 4435007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.